UK cost watchdog backs Roche lung drug

LONDON, May 10 (Reuters) - Britain's health cost watchdog said on Thursday that Roche's Tarceva cancer pill should be funded by the state as a first-line treatment for patients with lung cancer, after…
Read the full story: Reuters: Healthcare